Rationale, Feasibility and Acceptability of Ketogenic Diet for Cancer Treatment

Ketogenic diet has been used for more than 80 years as a successful dietary regimen for epilepsy. Recently, dietary modulation by carbohydrate depletion via ketogenic diet has been suggested as an important therapeutic strategy to selectively kill cancer cells and as adjuvant therapy for cancer trea...

Full description

Saved in:
Bibliographic Details
Published inJournal of cancer prevention Vol. 22; no. 3; pp. 127 - 134
Main Authors Chung, Hae-Yun, Park, Yoo Kyoung
Format Journal Article
LanguageEnglish
Published Korea (South) Korean Society of Cancer Prevention 01.09.2017
대한암예방학회
Subjects
Review
예방의학
Ketosis
High-fat diet
Ketogenic diet
Neoplasms
Online AccessGet full text
ISSN2288-3649
2288-3657
DOI10.15430/JCP.2017.22.3.127

Cover

Abstract Ketogenic diet has been used for more than 80 years as a successful dietary regimen for epilepsy. Recently, dietary modulation by carbohydrate depletion via ketogenic diet has been suggested as an important therapeutic strategy to selectively kill cancer cells and as adjuvant therapy for cancer treatment. However, some researchers insist ketogenic diet to be highly undesirable as ketogenic diet may trigger and/or exacerbate cachexia development and usually result in significant weight loss. This review revisits the meaning of physiological ketosis in the light of this evidence and considers possibility of the use of ketogenic diet for oncology patients. Article search was performed from 1985 through 2017 and finally 10 articles were analyzed. The review focused on the results of human trials for cancer patients and checked the feasibility of using ketogenic diet for cancer patients as adjuvant therapy. The main outcomes showed improvement of body weight changes, anthropometric changes, serum blood profiles, and reduction in novel marker for tumor progression, TKTL1, and increase of ketone body. Lactate concentration was reduced, and no significant changes were reported in the measurements of quality of life. Ketogenic diet may be efficacious in certain cancer subtypes whose outcomes appear to correlate with metabolic status, but the results are not yet supportive and inconsistent. Therefore, it warrants further studies.
AbstractList Ketogenic diet has been used for more than 80 years as a successful dietary regimen for epilepsy. Recently, dietary modulation by carbohydrate depletion via ketogenic diet has been suggested as an important therapeutic strategy to selectively kill cancer cells and as adjuvant therapy for cancer treatment. However, some researchers insist ketogenic diet to be highly undesirable as ketogenic diet may trigger and/or exacerbate cachexia development and usually result in significant weight loss. This review revisits the meaning of physiological ketosis in the light of this evidence and considers possibility of the use of ketogenic diet for oncology patients. Article search was performed from 1985 through 2017 and finally 10 articles were analyzed. The review focused on the results of human trials for cancer patients and checked the feasibility of using ketogenic diet for cancer patients as adjuvant therapy. The main outcomes showed improvement of body weight changes, anthropometric changes, serum blood profiles, and reduction in novel marker for tumor progression, TKTL1, and increase of ketone body. Lactate concentration was reduced, and no significant changes were reported in the measurements of quality of life. Ketogenic diet may be efficacious in certain cancer subtypes whose outcomes appear to correlate with metabolic status, but the results are not yet supportive and inconsistent. Therefore, it warrants further studies.Ketogenic diet has been used for more than 80 years as a successful dietary regimen for epilepsy. Recently, dietary modulation by carbohydrate depletion via ketogenic diet has been suggested as an important therapeutic strategy to selectively kill cancer cells and as adjuvant therapy for cancer treatment. However, some researchers insist ketogenic diet to be highly undesirable as ketogenic diet may trigger and/or exacerbate cachexia development and usually result in significant weight loss. This review revisits the meaning of physiological ketosis in the light of this evidence and considers possibility of the use of ketogenic diet for oncology patients. Article search was performed from 1985 through 2017 and finally 10 articles were analyzed. The review focused on the results of human trials for cancer patients and checked the feasibility of using ketogenic diet for cancer patients as adjuvant therapy. The main outcomes showed improvement of body weight changes, anthropometric changes, serum blood profiles, and reduction in novel marker for tumor progression, TKTL1, and increase of ketone body. Lactate concentration was reduced, and no significant changes were reported in the measurements of quality of life. Ketogenic diet may be efficacious in certain cancer subtypes whose outcomes appear to correlate with metabolic status, but the results are not yet supportive and inconsistent. Therefore, it warrants further studies.
Ketogenic diet has been used for more than 80 years as a successful dietary regimen for epilepsy. Recently, dietary modulation by carbohydrate depletion via ketogenic diet has been suggested as an important therapeutic strategy to selectively kill cancer cells and as adjuvant therapy for cancer treatment. However, some researchers insist ketogenic diet to be highly undesirable as ketogenic diet may trigger and/or exacerbate cachexia development and usually result in significant weight loss. This review revisits the meaning of physiological ketosis in the light of this evidence and considers possibility of the use of ketogenic diet for oncology patients. Article search was performed from 1985 through 2017 and finally 10 articles were analyzed. The review focused on the results of human trials for cancer patients and checked the feasibility of using ketogenic diet for cancer patients as adjuvant therapy. The main outcomes showed improvement of body weight changes, anthropometric changes, serum blood profiles, and reduction in novel marker for tumor progression, TKTL1, and increase of ketone body. Lactate concentration was reduced, and no significant changes were reported in the measurements of quality of life. Ketogenic diet may be efficacious in certain cancer subtypes whose outcomes appear to correlate with metabolic status, but the results are not yet supportive and inconsistent. Therefore, it warrants further studies. KCI Citation Count: 0
Ketogenic diet has been used for more than 80 years as a successful dietary regimen for epilepsy. Recently, dietary modulation by carbohydrate depletion via ketogenic diet has been suggested as an important therapeutic strategy to selectively kill cancer cells and as adjuvant therapy for cancer treatment. However, some researchers insist ketogenic diet to be highly undesirable as ketogenic diet may trigger and/or exacerbate cachexia development and usually result in significant weight loss. This review revisits the meaning of physiological ketosis in the light of this evidence and considers possibility of the use of ketogenic diet for oncology patients. Article search was performed from 1985 through 2017 and finally 10 articles were analyzed. The review focused on the results of human trials for cancer patients and checked the feasibility of using ketogenic diet for cancer patients as adjuvant therapy. The main outcomes showed improvement of body weight changes, anthropometric changes, serum blood profiles, and reduction in novel marker for tumor progression, TKTL1, and increase of ketone body. Lactate concentration was reduced, and no significant changes were reported in the measurements of quality of life. Ketogenic diet may be efficacious in certain cancer subtypes whose outcomes appear to correlate with metabolic status, but the results are not yet supportive and inconsistent. Therefore, it warrants further studies.
Author Chung, Hae-Yun
Park, Yoo Kyoung
AuthorAffiliation 1 Department of Food and Nutrition, Soongeui Women’s College, Seoul, Korea
2 Department of Medical Nutrition, Graduate School of East-West Medical Science, Kyung Hee University, Yongin, Korea
AuthorAffiliation_xml – name: 1 Department of Food and Nutrition, Soongeui Women’s College, Seoul, Korea
– name: 2 Department of Medical Nutrition, Graduate School of East-West Medical Science, Kyung Hee University, Yongin, Korea
Author_xml – sequence: 1
  givenname: Hae-Yun
  surname: Chung
  fullname: Chung, Hae-Yun
  organization: Department of Food and Nutrition, Soongeui Women‘s College, Seoul, Korea
– sequence: 2
  givenname: Yoo Kyoung
  surname: Park
  fullname: Park, Yoo Kyoung
  organization: Department of Medical Nutrition, Graduate School of East-West Medical Science, Kyung Hee University, Yongin, Korea
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29018777$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002266902$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNp9UctuEzEUtVARLaU_wALNEiQy-O3xBikK9AGViqqwtjyeO8V0YgfbQerf4yYhAhasruV7XrrnOToKMQBCLwluieAMv_u0-NJSTFRLactaQtUTdEJp182YFOro8Ob6GJ3l_B1jTJiQWtNn6JhqTDql1Am6ubXFx2AneNucg82-95MvD40NQzN3DtbF7n_i2HyGEu8geNd88FCaMaZmYYOD1CwT2LKCUF6gp6OdMpzt5yn6ev5xubicXd9cXC3m1zPHpCwzqaRyHGtBXNdLkOPI-ADEcqx6TWw_gGTjMDjG-97WoLrDDIMYpbDMacbYKXqz0w1pNPfOm2j9dt5Fc5_M_HZ5ZbimWDNVse932PWmX8HgasxkJ7NOfmXTw5b59yb4b1XnpxGSci4ezV7vBVL8sYFczMpnB9NkA8RNNkSLek-idVehr_70Opj8vngF0B3ApZhzgvEAIdhsmzW1WfPYrKHUMFObraTuH5LzZVtczeun_1F_AT69p9o
CitedBy_id crossref_primary_10_1038_s41419_019_1822_8
crossref_primary_10_1111_nbu_12693
crossref_primary_10_3390_metabo13091024
crossref_primary_10_1016_j_ejso_2018_04_016
crossref_primary_10_3390_healthcare7030089
crossref_primary_10_1186_s12906_021_03420_0
crossref_primary_10_1038_s41366_021_00866_7
crossref_primary_10_1080_15384101_2019_1644765
crossref_primary_10_2174_2211536608666181126093903
crossref_primary_10_3390_cimb43020042
crossref_primary_10_48124_husagbilder_917342
crossref_primary_10_1080_01635581_2020_1804947
crossref_primary_10_3389_fnins_2021_756970
crossref_primary_10_1007_s11033_024_09571_w
crossref_primary_10_1016_j_arr_2024_102531
crossref_primary_10_3892_ijo_2019_4942
crossref_primary_10_1002_jcsm_13466
crossref_primary_10_1039_D0FO01984D
crossref_primary_10_1155_jnme_7935879
crossref_primary_10_3389_fnmol_2021_689903
crossref_primary_10_1080_10408398_2020_1847030
crossref_primary_10_1097_CEJ_0000000000000918
crossref_primary_10_3390_microorganisms9071469
crossref_primary_10_34175_jno202002001
crossref_primary_10_1051_jbio_2020014
crossref_primary_10_1080_01635581_2021_1942081
crossref_primary_10_1007_s11101_024_09969_1
crossref_primary_10_1038_s41388_019_0976_2
crossref_primary_10_1007_s11154_018_9443_6
crossref_primary_10_1177_2050312120926877
crossref_primary_10_1080_14656566_2021_1873954
crossref_primary_10_1016_j_prp_2021_153622
crossref_primary_10_1371_journal_pone_0257725
crossref_primary_10_1007_s11154_019_09518_8
crossref_primary_10_1080_01635581_2022_2108073
crossref_primary_10_1111_jhn_12587
crossref_primary_10_1016_j_critrevonc_2024_104264
crossref_primary_10_1016_j_mmm_2019_12_004
crossref_primary_10_3390_biology12020158
crossref_primary_10_1002_jbm_a_37539
crossref_primary_10_1136_esmoopen_2018_000345
crossref_primary_10_3390_nu13093202
crossref_primary_10_1093_jn_nxx044
crossref_primary_10_3389_fnut_2022_802805
Cites_doi 10.1093/ajcn/47.1.42
10.3892/ijo.2014.2382
10.1126/scitranslmed.3003293
10.1158/1940-6207.CAPR-08-0188
10.7326/0003-4819-140-10-200405180-00006
10.1186/1471-2407-11-315
10.1186/s12986-016-0113-y
10.1186/1743-7075-7-74
10.1126/scitranslmed.aai8700
10.1371/journal.pone.0004567
10.1093/jn/137.1.236S
10.1126/science.1160809
10.1002/pros.20683
10.1016/j.maturitas.2010.01.004
10.1186/s13104-016-1959-9
10.1186/1743-7075-7-33
10.1016/0261-5614(91)90043-C
10.1542/peds.2009-0217
10.1158/1940-6207.CAPR-10-0071
10.1111/j.1532-5415.2009.02507.x
10.1186/1743-7075-8-54
10.1080/01635581.2013.804579
10.1186/1471-2407-8-122
10.1016/j.nut.2012.05.001
10.1007/s00508-005-0455-3
10.1038/sj.bjc.6601269
10.1634/theoncologist.2012-0164
10.3892/ol.2015.3923
ContentType Journal Article
Copyright Copyright © 2017 Korean Society of Cancer Prevention 2017
Copyright_xml – notice: Copyright © 2017 Korean Society of Cancer Prevention 2017
DBID AAYXX
CITATION
NPM
7X8
5PM
ACYCR
DOI 10.15430/JCP.2017.22.3.127
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
Korean Citation Index
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic


PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2288-3657
EndPage 134
ExternalDocumentID oai_kci_go_kr_ARTI_4920937
PMC5624453
29018777
10_15430_JCP_2017_22_3_127
Genre Journal Article
Review
GroupedDBID 5-W
8JR
AAYXX
ADBBV
ADRAZ
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
CITATION
DIK
HYE
KQ8
M48
OK1
PGMZT
RPM
NPM
7X8
5PM
ACYCR
ID FETCH-LOGICAL-c366t-6767c40951c8b6e6ff34de1a407b91abde63fddc34bba77798030e5f65a3c9333
IEDL.DBID M48
ISSN 2288-3649
IngestDate Tue Nov 21 21:42:55 EST 2023
Thu Aug 21 18:12:03 EDT 2025
Fri Jul 11 17:07:58 EDT 2025
Mon Jul 21 06:01:32 EDT 2025
Thu Apr 24 23:08:41 EDT 2025
Tue Jul 01 00:34:53 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Ketosis
High-fat diet
Ketogenic diet
Neoplasms
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c366t-6767c40951c8b6e6ff34de1a407b91abde63fddc34bba77798030e5f65a3c9333
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.15430/JCP.2017.22.3.127
PMID 29018777
PQID 1950181998
PQPubID 23479
PageCount 8
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_4920937
pubmedcentral_primary_oai_pubmedcentral_nih_gov_5624453
proquest_miscellaneous_1950181998
pubmed_primary_29018777
crossref_primary_10_15430_JCP_2017_22_3_127
crossref_citationtrail_10_15430_JCP_2017_22_3_127
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-09-01
PublicationDateYYYYMMDD 2017-09-01
PublicationDate_xml – month: 09
  year: 2017
  text: 2017-09-01
  day: 01
PublicationDecade 2010
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
PublicationTitle Journal of cancer prevention
PublicationTitleAlternate J Cancer Prev
PublicationYear 2017
Publisher Korean Society of Cancer Prevention
대한암예방학회
Publisher_xml – name: Korean Society of Cancer Prevention
– name: 대한암예방학회
References ref13
ref12
ref15
ref14
ref31
ref30
ref11
ref10
ref32
ref2
ref1
ref17
ref16
ref19
ref18
ref24
ref23
ref26
ref25
ref20
ref22
ref21
ref28
ref27
ref29
ref8
ref7
ref9
ref4
ref3
ref6
ref5
28202779 - Sci Transl Med. 2017 Feb 15;9(377):null
20097494 - Maturitas. 2010 May;66(1):5-15
20122025 - J Am Geriatr Soc. 2009 Nov;57 Suppl 2:S262-4
14520474 - Br J Cancer. 2003 Oct 6;89(7):1375-82
19596731 - Pediatrics. 2009 Aug;124(2):e300-4
27525031 - Nutr Metab (Lond). 2016 Aug 12;13:52
21794124 - Nutr Metab (Lond). 2011 Jul 27;8(1):54
17999389 - Prostate. 2008 Jan 1;68(1):11-9
20716631 - Cancer Prev Res (Phila). 2010 Sep;3(9):1124-31
22840388 - Nutrition. 2012 Oct;28(10):1028-35
24403443 - Anticancer Res. 2014 Jan;34(1):39-48
20831808 - Nutr Metab (Lond). 2010 Sep 10;7:74
23299773 - Oncologist. 2013;18(1):97-103
3122552 - Am J Clin Nutr. 1988 Jan;47(1):42-8
20412570 - Nutr Metab (Lond). 2010 Apr 22;7:33
15148063 - Ann Intern Med. 2004 May 18;140(10):769-77
26870251 - Oncol Lett. 2016 Jan;11(1):584-592
16839923 - Clin Nutr. 1991 Aug;10(4):228-32
19234595 - PLoS One. 2009;4(2):e4567
19470786 - Cancer Prev Res (Phila). 2009 Jun;2(6):557-65
19460998 - Science. 2009 May 22;324(5930):1029-33
23909728 - Nutr Cancer. 2013;65(6):843-9
18447912 - BMC Cancer. 2008 Apr 30;8:122
22323820 - Sci Transl Med. 2012 Mar 7;4(124):124ra27
16416368 - Wien Klin Wochenschr. 2005 Oct;117(19-20):685-92
28850991 - Laryngorhinootologie. 2017 Aug;96(8):514-518
2736521 - Cancer Res. 1989 Jul 15;49(14):3800-4
17182833 - J Nutr. 2007 Jan;137(1 Suppl):236S-242S
26946138 - BMC Res Notes. 2016 Mar 05;9:143
21791085 - BMC Cancer. 2011 Jul 26;11:315
24728273 - Int J Oncol. 2014 Jun;44(6):1843-52
References_xml – ident: ref11
  doi: 10.1093/ajcn/47.1.42
– ident: ref17
  doi: 10.3892/ijo.2014.2382
– ident: ref29
  doi: 10.1126/scitranslmed.3003293
– ident: ref26
  doi: 10.1158/1940-6207.CAPR-08-0188
– ident: ref32
  doi: 10.7326/0003-4819-140-10-200405180-00006
– ident: ref21
  doi: 10.1186/1471-2407-11-315
– ident: ref20
  doi: 10.1186/s12986-016-0113-y
– ident: ref23
  doi: 10.1186/1743-7075-7-74
– ident: ref5
  doi: 10.1126/scitranslmed.aai8700
– ident: ref7
  doi: 10.1371/journal.pone.0004567
– ident: ref27
– ident: ref2
  doi: 10.1093/jn/137.1.236S
– ident: ref9
– ident: ref8
  doi: 10.1126/science.1160809
– ident: ref24
  doi: 10.1002/pros.20683
– ident: ref3
  doi: 10.1016/j.maturitas.2010.01.004
– ident: ref4
– ident: ref19
  doi: 10.1186/s13104-016-1959-9
– ident: ref30
  doi: 10.1186/1743-7075-7-33
– ident: ref12
  doi: 10.1016/0261-5614(91)90043-C
– ident: ref31
  doi: 10.1542/peds.2009-0217
– ident: ref25
  doi: 10.1158/1940-6207.CAPR-10-0071
– ident: ref1
  doi: 10.1111/j.1532-5415.2009.02507.x
– ident: ref14
  doi: 10.1186/1743-7075-8-54
– ident: ref16
  doi: 10.1080/01635581.2013.804579
– ident: ref28
  doi: 10.1186/1471-2407-8-122
– ident: ref15
  doi: 10.1016/j.nut.2012.05.001
– ident: ref13
  doi: 10.1007/s00508-005-0455-3
– ident: ref10
– ident: ref22
  doi: 10.1038/sj.bjc.6601269
– ident: ref6
  doi: 10.1634/theoncologist.2012-0164
– ident: ref18
  doi: 10.3892/ol.2015.3923
– reference: 17182833 - J Nutr. 2007 Jan;137(1 Suppl):236S-242S
– reference: 16839923 - Clin Nutr. 1991 Aug;10(4):228-32
– reference: 19234595 - PLoS One. 2009;4(2):e4567
– reference: 20122025 - J Am Geriatr Soc. 2009 Nov;57 Suppl 2:S262-4
– reference: 22323820 - Sci Transl Med. 2012 Mar 7;4(124):124ra27
– reference: 28850991 - Laryngorhinootologie. 2017 Aug;96(8):514-518
– reference: 21794124 - Nutr Metab (Lond). 2011 Jul 27;8(1):54
– reference: 23299773 - Oncologist. 2013;18(1):97-103
– reference: 22840388 - Nutrition. 2012 Oct;28(10):1028-35
– reference: 24728273 - Int J Oncol. 2014 Jun;44(6):1843-52
– reference: 2736521 - Cancer Res. 1989 Jul 15;49(14):3800-4
– reference: 24403443 - Anticancer Res. 2014 Jan;34(1):39-48
– reference: 19596731 - Pediatrics. 2009 Aug;124(2):e300-4
– reference: 21791085 - BMC Cancer. 2011 Jul 26;11:315
– reference: 26870251 - Oncol Lett. 2016 Jan;11(1):584-592
– reference: 27525031 - Nutr Metab (Lond). 2016 Aug 12;13:52
– reference: 15148063 - Ann Intern Med. 2004 May 18;140(10):769-77
– reference: 18447912 - BMC Cancer. 2008 Apr 30;8:122
– reference: 20716631 - Cancer Prev Res (Phila). 2010 Sep;3(9):1124-31
– reference: 17999389 - Prostate. 2008 Jan 1;68(1):11-9
– reference: 20831808 - Nutr Metab (Lond). 2010 Sep 10;7:74
– reference: 23909728 - Nutr Cancer. 2013;65(6):843-9
– reference: 3122552 - Am J Clin Nutr. 1988 Jan;47(1):42-8
– reference: 20097494 - Maturitas. 2010 May;66(1):5-15
– reference: 16416368 - Wien Klin Wochenschr. 2005 Oct;117(19-20):685-92
– reference: 26946138 - BMC Res Notes. 2016 Mar 05;9:143
– reference: 19470786 - Cancer Prev Res (Phila). 2009 Jun;2(6):557-65
– reference: 19460998 - Science. 2009 May 22;324(5930):1029-33
– reference: 14520474 - Br J Cancer. 2003 Oct 6;89(7):1375-82
– reference: 20412570 - Nutr Metab (Lond). 2010 Apr 22;7:33
– reference: 28202779 - Sci Transl Med. 2017 Feb 15;9(377):null
SSID ssj0001356992
Score 2.2457552
SecondaryResourceType review_article
Snippet Ketogenic diet has been used for more than 80 years as a successful dietary regimen for epilepsy. Recently, dietary modulation by carbohydrate depletion via...
SourceID nrf
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 127
SubjectTerms Review
예방의학
Title Rationale, Feasibility and Acceptability of Ketogenic Diet for Cancer Treatment
URI https://www.ncbi.nlm.nih.gov/pubmed/29018777
https://www.proquest.com/docview/1950181998
https://pubmed.ncbi.nlm.nih.gov/PMC5624453
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002266902
Volume 22
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 대한암예방학회지, 2017, 22(3), , pp.127-134
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwELbacuGCQLzCozKIG2TZ2I4dHxCqFqpSxEOoK_Vm-VlWrRJIU4n-e2ay3hWLVohTpMSJnZlx_M14Mh8hLxKL8NlnTWljUKWwjSttqHTZ2CqFxsGKajHe8emzPJqL49P6dIes6I6yAC-3unbIJzXvLya_fl6_hQn_ZmTvEXz6-nj2FZO01ISxCZ9UTO2SG-N-EabyZbg_xlx4LfXIk8wYGAiXQuf_aLY_ZmOt2m37tA2G_p1N-cfydHib3Mq4kh4sDeEO2YntXfLlWw71xVcUsF7OhL2mtg30wGNCi81nukQ_xqEDa1p4-m4RBwpgls7QJHp6skpGv0fmh-9PZkdlZlAoPZdyKLEamxeIonzjZJQpcRFiZcGLc7qyLkTJUwieC-esUko3MOdjnWRtudec8_tkr-3a-JBQHn1VJVfbKMCl5FIn2WinhJ0GAVpVBalWsjI-lxdHlosLg24GyteAfA3K1zBmuAH5FuTl-p4fy-Ia_2z9HFRgzv3CYE1sPJ515rw3gPw_GKHZFKBWQZ6tNGRgouDuh21jd3VpkO8W4Ay4lwV5sNTYulPcTMbCiAVRG7pcN8AON6-0i-9jMW7Aj0LU_NH_DO4xuYlvtExRe0L2hv4qPgVMM7j90VD3x2DTb6SQ8mA
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Rationale%2C+Feasibility+and+Acceptability+of+Ketogenic+Diet+for+Cancer+Treatment&rft.jtitle=Journal+of+cancer+prevention&rft.au=%EC%A0%95%ED%98%9C%EC%97%B0&rft.au=%EB%B0%95%EC%9C%A0%EA%B2%BD&rft.date=2017-09-01&rft.pub=%EB%8C%80%ED%95%9C%EC%95%94%EC%98%88%EB%B0%A9%ED%95%99%ED%9A%8C&rft.issn=2288-3649&rft.eissn=2288-3657&rft.spage=127&rft.epage=134&rft_id=info:doi/10.15430%2FJCP.2017.22.3.127&rft.externalDBID=n%2Fa&rft.externalDocID=oai_kci_go_kr_ARTI_4920937
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2288-3649&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2288-3649&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2288-3649&client=summon